Basic info
Industry
biotechnology research
Sectors
vaccines
Biotechnology
dengue
oncolytics
clinical trials
Synthetic biology
virology
RSV
influenza
Genetics
Medical
infectious disease
Live-attenuated vaccine design
Date founded
2011
Funding rounds raised
Total raised
$25M
from 7 investors over 7 rounds
C
Codagenix Inc. raised $25M on February 15, 2023
Investors: Adjuvant Capital
C
Codagenix Inc. raised $4.4M on August 17, 2022
Investors: united-states-department-of-defense
C
Codagenix Inc. raised $2.2M on July 22, 2020
Investors: National Institute of Allergy and Infectious Diseases (NIAID)
C
Codagenix Inc. raised $20M on January 13, 2020
Investors: Adjuvant Capital
C
Codagenix Inc. raised $1M on April 24, 2019
Investors: united-states-department-of-defense
C
Codagenix Inc. raised $100K on December 16, 2014
Investors: Accelerate Long Island
C
Codagenix Inc. raised $100K on December 16, 2014
Investors: Accelerate Long Island